$0.7891
0.00811.04%
Last update: Oct 23, 5:02 PM
Biofrontera Inc (BFRI) Stock Price, Quote, News & History
BFRINASDAQ
Pelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology product offerings.
You can purchase shares of Biofrontera (NASDAQ:BFRI) through any online brokerage.
Other companies in Biofrontera’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Biofrontera has a consensus price target of $2.88.
The stock price for Biofrontera (NASDAQ: BFRI) is $0.784651 last updated October 23, 2026 at 5:02 PM EDT.
There are no upcoming dividends for Biofrontera.
Biofrontera does not have any upcoming earnings scheduled.
There is no upcoming split for Biofrontera.
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which...
